Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient malignant pleural mesothelioma
S. Karnan, A. Ota, M. N. Hasan, H. Murakami, M. L. Rahman, M. Wahiduzzaman, M. T. A. Shihan, N. Jahan, L. Q. Vu, I. Hanamura, A. Inoko, M. Riku, H. Ito, Y. Kaneko, Y. Lin, , Y. Hosokawa
This study identifies FASN inhibition as a therapeutic strategy for NF2/CDKN2A-deficient MPM, showing reduced tumor growth in xenograft models.
bioRxiv · Jul 14, 2024 · PreprintCancer Biology